MedTrace Logo

Accuracy of Scoring Systems for Risk Assessment in Neonatal Intensive Care Unit

NCT05763316 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-03-15

No results posted yet for this study

Summary

Early detection of neonates with higher risk of death is quite important for paying more attention to these cases, timely referral to tertiary neonatal intensive care unit (NICU), and provision of meticulous critical care, which ultimately may improve outcomes. Several scoring systems have recently been developed for assessment of the intensity of illness and prognosticate the risk of not only neonatal mortality but also short- and long-term morbidities. The accuracy of these scoring systems has been investigated in several NICUs from different countries, such as USA, UK, Canada, Brazil, India, and Iran. Previous Egyptian studies have investigated the accuracy of Clinical Risk Index for Babies II (CRIB II), Score for Neonatal Acute Physiology II (SNAP-II) and its Perinatal Extension II (SNAPPE-II). However, the accuracy of Sensorium, temperature, oxygenation, perfusion, skin color, and blood sugar (STOPS), Modified Sick neonatal Score (MSNS), and neonatal sequential organ failure assessment (nSOFA) has not been investigated in Egyptian NICUs. Therefore, more studies are required to investigate the utility and accuracy of neonatal risk assessment scores in Egyptian NICUs.

Conditions

  • Neonatal Death

Interventions

OTHER

CRIB II

Calculate Clinical Risk Index for Babies II score

OTHER

SNAP-II

Calculate Score for Neonatal Acute Physiology II

OTHER

SNAPPE-II

Calculate Score for Neonatal Acute Physiology Perinatal Extension II

OTHER

STOPS

Calculate Sensorium, temperature, oxygenation, perfusion, skin color, and blood sugar score

OTHER

MSNS

Calculate Modified Sick neonatal Score

OTHER

nSOFA

Calculate neonatal sequential organ failure assessment

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Montaser M Mohamed, MD, PhD · Sohag University

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-12
Primary Completion
2024-04-01
Completion
2024-04-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763316 on ClinicalTrials.gov